Condition: Tricuspid Regurgitation · Sponsor: Laplace Interventional, Inc
The objective of the study is to assess the safety and technical feasibility of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
This description comes directly from the study's public registry record.
Ryan Gladney · 763-465-9501 · clinical@laplaceint.com
Always discuss trial participation with your own doctor first.
| Tucson Medical Center | Tucson, Arizona, United States | Recruiting |
| Kaiser Permanente | San Francisco, California, United States | Recruiting |
| Piedmont Hospital | Atlanta, Georgia, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Dartmouth-Hitchcock Medical Center | Lebanon, New Hampshire, United States | Recruiting |
| Montefiore Medical Center | The Bronx, New York, United States | Recruiting |
| University Hospitals, Cleveland Medical Center | Cleveland, Ohio, United States | Recruiting |
| Oklahoma Heart Institute | Tulsa, Oklahoma, United States | Recruiting |
| Providence Heart Institute | Portland, Oregon, United States | Recruiting |
| Vanderbilt University Medical Center | Nashville, Tennessee, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06183684